rs75028796
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000419.5(ITGA2B):c.1913_1914insT(p.Cys639MetfsTer22) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000192 in 1,560,796 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
ITGA2B
NM_000419.5 frameshift
NM_000419.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.06
Genes affected
ITGA2B (HGNC:6138): (integrin subunit alpha 2b) This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-44378675-T-TA is Pathogenic according to our data. Variant chr17-44378675-T-TA is described in ClinVar as [Pathogenic]. Clinvar id is 996206.Status of the report is reviewed_by_expert_panel, 3 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGA2B | NM_000419.5 | c.1913_1914insT | p.Cys639MetfsTer22 | frameshift_variant | 19/30 | ENST00000262407.6 | NP_000410.2 | |
ITGA2B | XM_011524749.2 | c.2066_2067insT | p.Cys690MetfsTer22 | frameshift_variant | 19/29 | XP_011523051.2 | ||
ITGA2B | XM_011524750.2 | c.2066_2067insT | p.Cys690MetfsTer22 | frameshift_variant | 19/29 | XP_011523052.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGA2B | ENST00000262407.6 | c.1913_1914insT | p.Cys639MetfsTer22 | frameshift_variant | 19/30 | 1 | NM_000419.5 | ENSP00000262407 | P1 | |
ITGA2B | ENST00000648408.1 | c.1344_1345insT | p.Cys450MetfsTer22 | frameshift_variant | 15/25 | ENSP00000498119 | ||||
ITGA2B | ENST00000592462.5 | n.708_709insT | non_coding_transcript_exon_variant | 8/15 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000142 AC: 2AN: 1408592Hom.: 0 Cov.: 32 AF XY: 0.00000144 AC XY: 1AN XY: 695454
GnomAD4 exome
AF:
AC:
2
AN:
1408592
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
695454
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74364
GnomAD4 genome
AF:
AC:
1
AN:
152204
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
Glanzmann thrombasthenia Pathogenic:1
Pathogenic, reviewed by expert panel | curation | ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen | Dec 07, 2020 | The ITGA2B frameshift variant NM_000419.5:c.1913dup (p.Cys639MetfsTer22) introduces a premature termination codon and the resulting mRNA product is predicted to undergo nonsense mediated decay, leading to loss of normal protein function. This variant has been observed in homozygosity in one individual (Patient LF, PMID: 12083483) and heterozygosity in two individuals (CabGT-2, PMID: 20020534 and Patient ER, PMID: 12083483), at least one of which was reported to have a phenotype specific for Glanzmann's thrombasthenia (GT). Furthermore, this variant is extremely rare in population databases. In summary, this variant meets criteria to be classified as pathogenic for GT. GT-specific criteria applied: PVS1, PP4_strong, PM2_supporting, PM3_supporting. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at